Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 02, 2026
Multiple myeloma is treatable, not curable. Is that set to change?
Some experts believe a ‘functional cure’ is already within reach
When it comes to cancer trials, what’s the (end)point?
New endpoint in multiple myeloma could mean faster drug approvals. Are more endpoint tweaks on the way?
Once-weekly bortezomib is enough to treat multiple myeloma
From Dr. Rahul Banerjee, Clinical Research Division